Cambient Family Office LLC Acquires New Shares in Danaher Corporation $DHR

Cambient Family Office LLC bought a new position in Danaher Corporation (NYSE:DHR) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 17,495 shares of the conglomerate’s stock, valued at approximately $4,011,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. McLaughlin Asset Management Inc. purchased a new stake in shares of Danaher during the fourth quarter valued at $495,000. Wick Capital Partners LLC bought a new stake in shares of Danaher in the fourth quarter worth approximately $761,000. Compound Planning Inc. raised its holdings in shares of Danaher by 47.1% during the fourth quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock valued at $2,187,000 after purchasing an additional 3,060 shares during the last quarter. Invesco Ltd. lifted its position in Danaher by 8.1% during the fourth quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock valued at $943,201,000 after purchasing an additional 307,095 shares during the period. Finally, Evansbrook LLC bought a new stake in Danaher in the 4th quarter worth approximately $282,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 0.0%

Shares of Danaher stock opened at $177.74 on Friday. The company’s fifty day simple moving average is $179.99 and its 200-day simple moving average is $203.25. The stock has a market capitalization of $125.80 billion, a PE ratio of 34.38, a P/E/G ratio of 2.27 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.88 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Morgan Stanley decreased their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. UBS Group cut their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Wells Fargo & Company cut their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.